Zeaxanthin dipalmitate therapeutically improves hepatic functions in an alcoholic fatty liver disease model through modulating mapk pathway

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Xiao, Jia ^a,c,d   Wang, Jiteng ^b   Xing, Feiyue ^a   Han, Tao ^b   Jiao, Rui ^a   Liong, Emily C ^c   Fung, Man Lung ^c   So, Kwok Fai ^a,c   Tipoe, George L ^c  

^a JINAN UNIVERSITY   (China)

^b ZHEJIANG OCEAN UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d SHENZHEN THIRD PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2E1; FAT DROPLET; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIVER PROTECTIVE AGENT; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; ZEAXANTHIN DIPALMITATE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 8 ISOPROSTANE; ALANINE AMINOTRANSFERASE; ALCOHOL; ALCOHOL DEHYDROGENASE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ASPARTATE AMINOTRANSFERASE; CASPASE 3; CASPASE 7; CATALASE; CHOLESTEROL; COPPER ZINC SUPEROXIDE DISMUTASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MALONALDEHYDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN; PROTEIN BCL 2; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ALCOHOL BLOOD LEVEL; ALCOHOLIC FATTY LIVER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG STRUCTURE; ENZYME INHIBITION; FEMALE; HEPATITIS; IN VITRO STUDY; IN VIVO STUDY; LIVER HISTOLOGY; LIVER PROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; WEIGHT REDUCTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ANIMAL CELL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL VIABILITY; CHOLESTEROL BLOOD LEVEL; DOWN REGULATION; ENZYME ACTIVITY; ENZYME MODIFICATION; HISTOPATHOLOGY; LIPID PEROXIDATION; LIVER FUNCTION; PILOT STUDY; PROPHYLAXIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; STRUCTURE ANALYSIS; TOXICITY TESTING; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

EID: 84899676267     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095214.t001     Document Type: Article

References (32)

1. Zhou YJ, Li YY, Nie YQ, Ma JX, Lu LG, et al. (2007) Prevalence of fatty liver disease and its risk factors in the population of South China. World J Gastroenterol 13: 6419-6424.
2. Savolainen VT, Liesto K, Mannikko A, Penttila A, Karhunen PJ (1993) Alcohol consumption and alcoholic liver disease: evidence of a threshold level of effects of ethanol. Alcohol Clin Exp Res 17: 1112-1117. (Pubitemid 24000535)
3. Sozio M, Crabb DW (2008) Alcohol and lipid metabolism. Am J Physiol Endocrinol Metab 295: E10-16.
4. Orman ES, Odena G, Bataller R (2013) Alcoholic liver disease: pathogenesis, management, and novel targets for therapy. J Gastroenterol Hepatol 28 Suppl 1: 77-84.
5. Breitkopf K, Nagy LE, Beier JI, Mueller S, Weng H, et al. (2009) Current experimental perspectives on the clinical progression of alcoholic liver disease. Alcohol Clin Exp Res 33: 1647-1655.
6. Firdous AP, Sindhu ER, Kuttan R (2011) Hepato-protective potential of carotenoid meso-zeaxanthin against paracetamol, CCl4 and ethanol induced toxicity. Indian J Exp Biol 49: 44-49.
7. Kozuki Y, Miura Y, Yagasaki K (2000) Inhibitory effects of carotenoids on the invasion of rat ascites hepatoma cells in culture. Cancer Lett 151: 111-115. (Pubitemid 30155592)
8. Chamberlain SM, Hall JD, Patel J, Lee JR, Marcus DM, et al. (2009) Protective effects of the carotenoid zeaxanthin in experimental nonalcoholic steatohepatitis. Dig Dis Sci 54: 1460-1464.
9. Tapiero H, Townsend DM, Tew KD (2004) The role of carotenoids in the prevention of human pathologies. Biomed Pharmacother 58: 100-110. (Pubitemid 38264535)
10. Xiao J, Liong EC, Ching YP, Chang RC, Fung ML, et al. (2013) Lycium barbarum polysaccharides protect rat liver from non-alcoholic steatohepatitisinduced injury. Nutr Diabetes 3: e81.
11. Xiao J, Liong EC, Ching YP, Chang RC, So KF, et al. (2012) Lycium barbarum polysaccharides protect mice liver from carbon tetrachloride-induced oxidative stress and necroinflammation. J Ethnopharmacol 139: 462-470.
12. Kim HP, Lee EJ, Kim YC, Kim J, Kim HK, et al. (2002) Zeaxanthin dipalmitate from Lycium chinense fruit reduces experimentally induced hepatic fibrosis in rats. Biol Pharm Bull 25: 390-392. (Pubitemid 39663297)
13. Chen JH, Tipoe GL, Liong EC, So HS, Leung KM, et al. (2004) Green tea polyphenols prevent toxin-induced hepatotoxicity in mice by down-regulating inducible nitric oxide-derived prooxidants. Am J Clin Nutr 80: 742-751. (Pubitemid 41115541)
14. Kim SY, Kim HP, Huh H, Kim YC (1997) Antihepatotoxic zeaxanthins from the fruits ofLycium chinense. Arch Pharm Res 20: 529-532. (Pubitemid 127697214)
15. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, et al. (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55: 611-622.
16. Cederbaum AI, Lu Y, Wu D (2009) Role of oxidative stress in alcohol-induced liver injury. Arch Toxicol 83: 519-548.
17. Lu Y, Cederbaum AI (2008) CYP2E1 and oxidative liver injury by alcohol. Free Radic Biol Med 44: 723-738.
18. Xiao J, Ching YP, Liong EC, Nanji AA, Fung ML, et al. (2013) Garlic-derived S-allylmercaptocysteine is a hepato-protective agent in non-alcoholic fatty liver disease in vivo animal model. Eur J Nutr 52: 179-191.
19. Berra E, Diaz-Meco MT, Moscat J (1998) The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway. J Biol Chem 273: 10792-10797. (Pubitemid 28227697)
20. Scaglioni F, Ciccia S, Marino M, Bedogni G, Bellentani S (2011) ASH and NASH. Dig Dis 29: 202-210.
21. Cheng D, Kong H (2011) The effect of Lycium barbarum polysaccharide on alcohol-induced oxidative stress in rats. Molecules 16: 2542-2550.
22. Bishayee A, Darvesh AS, Politis T, McGory R (2010) Resveratrol and liver disease: from bench to bedside and community. Liver Int 30: 1103-1114.
23. Park JH, Kim Y, Kim SH (2012) Green tea extract (Camellia sinensis) fermented by Lactobacillus fermentum attenuates alcohol-induced liver damage. Biosci Biotechnol Biochem 76: 2294-2300.
24. Das SK, Vasudevan DM (2006) Protective effects of silymarin, a milk thistle (Silybium marianum) derivative on ethanol-induced oxidative stress in liver. Indian J Biochem Biophys 43: 306-311.
25. Limdi JK, Hyde GM (2003) Evaluation of abnormal liver function tests. Postgrad Med J 79: 307-312. (Pubitemid 36819456)
26. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, et al. (2012) Inflammasomemediated dysbiosis regulates progression of NAFLD and obesity. Nature 482: 179-185.
27. Wheeler MD (2003) Endotoxin and Kupffer cell activation in alcoholic liver disease. Alcohol Res Health 27: 300-306. (Pubitemid 40685569)
28. Gouillon Z, Lucas D, Li J, Hagbjork AL, French BA, et al. (2000) Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole. Proc Soc Exp Biol Med 224: 302-308. (Pubitemid 30643509)
29. Lu Y, Wu D, Wang X, Ward SC, Cederbaum AI (2010) Chronic alcoholinduced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice. Free Radic Biol Med 49: 1406-1416.
30. Carelli S, Hebda DM, Traversa MV, Messaggio F, Giuliani G, et al. (2012) A specific combination of zeaxanthin, spermidine and rutin prevents apoptosis in human dermal papilla cells. Exp Dermatol 21: 953-955.
31. Inbaraj BS, Lu H, Hung CF, Wu WB, Lin CL, et al. (2008) Determination of carotenoids and their esters in fruits of Lycium barbarum Linnaeus by HPLCDAD- APCI-MS. J Pharm Biomed Anal 47: 812-818.
32. Li Y, Gao C, Shi Y, Tang Y, Liu L, et al (2013) Carbon monoxide alleviates ethanol-induced oxidative damage and inflammatory stress through activating p38 MAPK pathway.